Medicamen Biotec (MEDICAMEQ)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹259.48 |
| Market Cap | ₹408.51 Cr |
| P/E Ratio | 46.21 |
| ROCE | 6.77% |
| ROE | 4.01% |
| Dividend Yield | 0.33% |
| Profit Growth | 2.78% |
| Debt/Equity | 0.14 |
| Sales Growth | 5.71% |
| Promoter Holding | 40.46% |
| 52-Week Range | ₹216.95 — ₹447.65 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹164.34 |
Medicamen Biotec trades with a P/E ratio of 46.21, ROCE of 6.77%, ROE of 4.01%, profit growth of 2.78%, debt-to-equity of 0.14.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer